We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
2101
DELISTED
Dynavax Technologies
DVAX
| $1.26M | ﹤0.01% |
128,231
-7,678
| -6% | -$63.3K |
|
2102
Liberty Energy
LBRT
$3.25B
| $1.26M | ﹤0.01% |
111,722
+4,956
| +5% | +$59.6K |
|
2103
ANI Pharmaceuticals
ANIP
$1.78B
| $1.26M | ﹤0.01% |
34,824
+1,150
| +3% | +$36K |
|
2104
Horizon Bancorp
HBNC
$1.04B
| $1.26M | ﹤0.01% |
67,620
-3,696
| -5% | -$65.7K |
|
2105
Theravance Biopharma
TBPH
$877M
| $1.26M | ﹤0.01% |
61,515
-3,917
| -6% | -$74.4K |
|
2106
Dillards
DDS
$9.56B
| $1.25M | ﹤0.01% |
12,968
-1,883
| -13% | -$153K |
|
2107
Camping World
CWH
$653M
| $1.25M | ﹤0.01% |
34,317
-2,294
| -6% | -$81.6K |
|
2108
PAR Technology
PAR
$735M
| $1.25M | ﹤0.01% |
19,087
-867
| -4% | -$64.4K |
|
2109
Cerus
CERS
$474M
| $1.25M | ﹤0.01% |
207,519
-11,860
| -5% | -$80.7K |
|
2110
Team
TISI
$77.7M
| $1.25M | ﹤0.01% |
10,799
+90
| +0.8% | +$9.87K |
|
|
SP
2111
DELISTED
SP Plus Corporation
SP
| $1.24M | ﹤0.01% |
37,911
-2,202
| -5% | -$71.1K |
|
|
MRC
2112
DELISTED
MRC Global
MRC
| $1.24M | ﹤0.01% |
137,303
-7,615
| -5% | -$64.8K |
|
|
TBIO
2113
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.24M | ﹤0.01% |
75,227
-5,315
| -7% | -$121K |
|
2114
Weis Markets
WMK
$1.86B
| $1.24M | ﹤0.01% |
21,913
+4,949
| +29% | +$265K |
|
|
FFIC
2115
DELISTED
Flushing Financial
FFIC
| $1.23M | ﹤0.01% |
58,097
-2,918
| -5% | -$60.3K |
|
|
DHIL
2116
DELISTED
Diamond Hill
DHIL
| $1.23M | ﹤0.01% |
7,900
+1,713
| +28% | +$264K |
|
2117
Omeros
OMER
$959M
| $1.23M | ﹤0.01% |
69,217
-6,579
| -9% | -$128K |
|
2118
Manitowoc
MTW
$675M
| $1.23M | ﹤0.01% |
59,660
-4,015
| -6% | -$66.4K |
|
|
CDMO
2119
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.23M | ﹤0.01% |
67,320
-2,920
| -4% | -$48.5K |
|
|
JAMF
2120
DELISTED
Jamf
JAMF
| $1.23M | ﹤0.01% |
34,689
+11,534
| +50% | +$421K |
|
2121
Matrix Service
MTRX
$335M
| $1.22M | ﹤0.01% |
93,024
+319
| +0.3% | +$4.26K |
|
2122
Madrigal Pharmaceuticals
MDGL
$11.8B
| $1.22M | ﹤0.01% |
10,425
-911
| -8% | -$106K |
|
|
ZGNX
2123
DELISTED
Zogenix, Inc.
ZGNX
| $1.2M | ﹤0.01% |
61,653
-9,215
| -13% | -$189K |
|
|
GBIO
2124
DELISTED
Generation Bio
GBIO
| $1.2M | ﹤0.01% |
4,220
+2,850
| +208% | +$912K |
|
|
ECHO
2125
EchoStar
ECHO
$26.2B
| $1.2M | ﹤0.01% |
49,949
-599
| -1% | -$14.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.